Amphastar Pharma (NQ: AMPH )

18.37 USD -0.14 (-0.76%)

Streaming Delayed Price Updated: 1:01 PM EDT, Sep 29, 2020 Add to My Watchlist

Price and Volume

Volume	72,192
Open	18.49
Bid (Size)	18.36 (6)
Ask (Size)	18.38 (3)
Prev. Close	18.51
Today's Range	18.29 - 18.66
52wk Range	12.32 - 22.69
Shares Outstanding	46,614,060
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference

September 03, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020

August 06, 2020

Reports Net Revenues of $85.8 Million for the Three Months Ended June 30, 2020

Performance

YTD	-5.06%	-5.06%
1 Month	-9.86%	-9.86%
3 Month	-16.95%	-16.95%
6 Month	+21.49%	+21.49%
1 Year	-7.36%	-7.36%

More News

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020

July 30, 2020

Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference

June 19, 2020

Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference

June 12, 2020

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial

June 09, 2020

Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

June 02, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020

May 07, 2020

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020

May 04, 2020

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

April 27, 2020

Snag This Bargain Even Cheaper Than Director Maris Did

August 21, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.